is there still a glp-1 shortage Out of Shortage, Into Controversy: The Fight Over Compounding GLP-1 drug shortage resolution boosts

Current clinical evidence suggests no direct contraindication between tirzepatide therapy and magnesium glycinate supplementation

Nat Commun 12:7147 Payan BA, Vanarsa K, Ding H, Soomro S, Baig S, Du Y, Hicks J, Mohan C (2018) Epigallocatechin-3-gallate (egcg) ameliorates dextran sulfate sodium (dss)induced inflammatory bowel disease

doi: 10.1126/sciadv.adw5001

All products are supplied solely for laboratory research use

Expanding that collaboration to liquid carnitine makes sense: these products get used daily, often multiple times

Contraindications: None known, except for use during some forms of chemotherapy and radiation where antioxidants are contraindicated die to their inhibition of the free radical formation which is an integral part of the therapeutic mechanism